Loading company…
PT Etana Biotechnologies Indonesia develops biopharmaceuticals for cancer and other diseases.
Founded in 2014 and based in Jakarta, Indonesia, PT Etana Biotechnologies Indonesia develops pharmaceuticals for cancer, metabolic and autoimmune diseases. Its products include epoetin alfa and a bevacizumab biosimilar, and it is developing monoclonal antibody drugs. In March 2023, it raised venture funding led by DEG, East Venture, HighLight Capital and YF Capital. The company planned to strengthen its pipeline, research and manufacturing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in